live attenuated zoster vaccine

ApprovedVaccine

CChangchun BCHT Biotechnology Co.

live attenuated zoster vaccine is one of 52 biologic programs targeting Influenza. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

InfluenzaActive, not recruiting

AsthmaActive, not recruiting

InfluenzaApproved

Active, not recruiting

AsthmaApproved

Active, not recruiting

Competition

Competitive Landscape

1053 competitors in Influenza

#DrugCompanyPhaseTrials

live attenuated zoster vaccine

CChangchun BCHT Biotechnology Co.

Approved

12 2

Fluzone

Sanofi

Preclinical

16 3

Fluzone

GSK

Preclinical

37 4

Trexall

Alnylam Pharmaceuticals

Preclinical

1 5

Avigan

AAppili Therapeutics Inc.

Preclinical

6 6

Quadrivalent Influenza Vaccine

Sanofi

Preclinical

30 7

COMIRNATY

Pfizer

Preclinical

1 8

Antihistamine

Arrowhead Pharmaceuticals

Preclinical

1 9

PD-1/PD-L1 Inhibitors

CChuangzhen Chen

Preclinical

1 10

Xuanfei Baidu Granule

PPeking University People's Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2030

Post-ApprovalRecruiting

Influenza

NCT07240922

Clinical

Trials by Indication[1]

Influenza12 trials

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Unknown status·CChangchun BCHT Biotechnology Co.·Phase 1·NCT05056519·160 enrolled

The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study

Recruiting·TThe University of Hong Kong·Phase 4·NCT07240922·600 enrolled

Efficacy & Safety of Nasal Influenza Immunisation in Children

Completed·IImperial College London·Phase 4·NCT02549365·276 enrolled

Show 9 more trials

Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years

Completed·SSt. Louis University·Phase 4·NCT03101462·38 enrolled

Nasal and Systemic Immune Responses to Nasal Influenza Vaccine

Completed·IImperial College Healthcare NHS Trust·N/A·NCT04110366·48 enrolled

Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine

Completed·PPatricia L. Hibberd·Phase 1·NCT01545349·30 enrolled

Live Versus Inactivated Influenza Vaccine Study in Hutterite Children

Completed·MMcMaster University·Phase 4·NCT01653015·4,611 enrolled

Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children

Completed·IImperial College London·Phase 4·NCT03735147·12 enrolled

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Unknown status·CChangchun BCHT Biotechnology Co.·Phase 2·NCT05284851·2,520 enrolled

Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

Completed·UUniversity of Rochester·Phase 4·NCT01246999·34 enrolled

Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants

Terminated·UUniversity of Rochester·Phase 4·NCT01194297·3 enrolled

Revealing Protective Immunity to Influenza Using Systems Immunology

Completed·EEmory University·Phase 4·NCT06501963·51 enrolled

Efficacy1 trial

Study on Efficacy of Attenuated Zoster Vaccine, Live

Completed·CChangchun BCHT Biotechnology Co.·Phase 3·NCT04334577·25,000 enrolled

Clinical Trial1 trial

To Explore a Bridging Index for the Effectiveness of the Clinical Trial

Unknown status·CChangchun BCHT Biotechnology Co.·N/A·NCT04825340·450 enrolled

Immunity1 trial

Intranasal LAIV Mucosal Immunity Examination

Not yet recruiting·UUniversity of Maryland, Baltimore·Phase 4·NCT07093281·25 enrolled

Asthma1 trial

Safety of LAIV4 in Children With Asthma

Completed·VVanderbilt University Medical Center·Phase 4·NCT03600428·152 enrolled

2 more indications

Flu Vaccine1 trial

The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets

Completed·SStanford University·Phase 1·NCT03898986·18 enrolled

Immune Response1 trial

Evaluating Immune Response to Seasonal FluMist in Healthy Adults

Terminated·NNational Center for Occupational Health and Infection Control·N/A·NCT01673425·5 enrolled

Sources

References

[1]
ClinicalTrials.gov — 18 trial records for live attenuated zoster vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — live attenuated zoster vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for live attenuated zoster vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Changchun BCHT Biotechnology Co. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Approved[1]
Company: CChangchun BCHT Biotechnology Co.

live attenuated zoster vaccine

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2030

Trials by Indication[1]

Influenza12 trials

Efficacy1 trial

Clinical Trial1 trial

Immunity1 trial

Asthma1 trial

Flu Vaccine1 trial

Immune Response1 trial

References

Drug Info

Quick Facts

Related News